Brenan, J.G., M.S. Alilio, and A. Mills. Conquering the intolerable burden of malaria: what’s new, whats needed: a summary. American J. of Tropical Medicine and Hygiene, 2004;71 (Suppl 2);1-15.
Centers for Disease Control (CDC). Treatment of Malaria (Guidelines for Clinicians), June 28,2004.
Manual of Clinical Microbiology, 8th Edition, 2003. Plasmodium and Babesia, pp1944-59.
Tijtra, Emiliana, S. Suprianto, J. McBoon, B.J. Currie, and N.M. Antsey. Persistent ICT Malaria P.f./ P.v. Panmalarial and HRP2 Antigen Reactivity after treatment of Plasmodium falciparum Malaria Is Associated with Gametocytemia and Results in False-Positive Diagnoses of Plasmodium vivax in Convalescence. J. of Clinical Microbiology, March 2001;39: 1025-1031.
Moody, Anthony. Rapid Diagnostic Tests for Malaria Parasites. Clinical Microbiology Reviews, Jan,2002; 15: 66-78.
Iqbal, J.,A. Sher and A. Rab. Plasmodium falciparum Histidine-Rich Protein 2- Based Immunocapture Diagnostic Assay for Malaria: Cross-Reactivity with Rheumatoid Factors. J. of Clinical Microbiology, March 2000: 38:1184-1186.
Review Criteria for Assessment of Rheumatoid Factor (Rf) IN Vitro Diagnostic Devices Using Enzyme-Linked Immunoassay (EIA), Enzyme Linked Immunosorbent Assay (ELISA0, Particle Agglutination Tests, and Laser and Rate Nephelometry. FDA Guidance Document; February 21, 1997.
Lysenko, A. JA. And A.E. Beljaev. An analysis of the Geographical Distribution of Plasmodium ovale. World Health Organization Bulletin, 1969; 40:383-394.
Collins, W.E. and G.M. Jeffrey. Plasmodium ovale. Parasite and Disease. Clinical Microbiology Reviews, July 2005; 18:570-581.
BinaxNOW® Malaria Package Insert.